Iovance’s AMTAGVI (lifileucel) gets US FDA accelerated approval for advanced melanoma
AMTAGVI is the first FDA-approved T cell therapy for a solid tumor cancer and first treatment option for advanced melanoma after…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.